{"title":"Synthetic Biology-Based Heterologous Expression and Purification of Enterocin A: Advancing Antimicrobial Peptide Applications.","authors":"Mohamed Merzoug,Zohra Yasmine Zater,Khédidja Mosbahi,Daniel Walker,Svetoslav Dimitrov Todorov,Djamal Saidi","doi":"10.1002/mnfr.70260","DOIUrl":null,"url":null,"abstract":"Antibiotic resistance is a global health challenge, requiring the development of alternative antimicrobial strategies where pathogens can be inhibited by safe antimicrobials with different modes of action and less possibilities for developing resistance. Bacteriocins, ribosomally synthesized antimicrobial peptides produced by lactic acid bacteria, have emerged as promising natural agents for food preservation and pathogen control. This study reports the design and synthesis of a complete genetic cassette encoding the mature form of enterocin A, a bacteriocin derived from Enterococcus faecium. The vector (pJ404-pEntApep), containing the synthetic entA gene, was entirely constructed de novo and included as functional regulatory elements along with an N-terminal His6-tag for efficient purification. The genetic construct was validated through PCR and followed a sequencing of the generated amplicon. Expression in Escherichia coli BL21 (DE3) under optimized conditions (28°C, 0.5 mM IPTG) resulted in production of recombinant leaderless enterocin A (EntA), primarily in the form of inclusion bodies. Solubilization using 6 M guanidine-HCl, followed by protein refolding, enabled efficient recovery. The refolded peptide was purified via Ni-NTA affinity chromatography, with recorded elution at 400 mM imidazole. The purified enterocin A demonstrated potent antimicrobial activity against multidrug-resistant pathogens, including Staphylococcus aureus subsp. aureus ATCC 25923, Pseudomonas aeruginosa ATCC 27853, Acinetobacter lwoffii GPE 3002, Micrococcus luteus GPE 3001, and Bacillus cereus GPE 3003, with minimum inhibitory concentration (MIC) values ranging from 27 to 109 µg/mL. This study establishes a robust and cost-effective method for producing bioactive bacteriocins from inclusion bodies, underscoring their potential as sustainable alternatives to conventional antibiotics and chemical preservatives.","PeriodicalId":212,"journal":{"name":"Molecular Nutrition & Food Research","volume":"67 1","pages":"e70260"},"PeriodicalIF":4.2000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Nutrition & Food Research","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1002/mnfr.70260","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Antibiotic resistance is a global health challenge, requiring the development of alternative antimicrobial strategies where pathogens can be inhibited by safe antimicrobials with different modes of action and less possibilities for developing resistance. Bacteriocins, ribosomally synthesized antimicrobial peptides produced by lactic acid bacteria, have emerged as promising natural agents for food preservation and pathogen control. This study reports the design and synthesis of a complete genetic cassette encoding the mature form of enterocin A, a bacteriocin derived from Enterococcus faecium. The vector (pJ404-pEntApep), containing the synthetic entA gene, was entirely constructed de novo and included as functional regulatory elements along with an N-terminal His6-tag for efficient purification. The genetic construct was validated through PCR and followed a sequencing of the generated amplicon. Expression in Escherichia coli BL21 (DE3) under optimized conditions (28°C, 0.5 mM IPTG) resulted in production of recombinant leaderless enterocin A (EntA), primarily in the form of inclusion bodies. Solubilization using 6 M guanidine-HCl, followed by protein refolding, enabled efficient recovery. The refolded peptide was purified via Ni-NTA affinity chromatography, with recorded elution at 400 mM imidazole. The purified enterocin A demonstrated potent antimicrobial activity against multidrug-resistant pathogens, including Staphylococcus aureus subsp. aureus ATCC 25923, Pseudomonas aeruginosa ATCC 27853, Acinetobacter lwoffii GPE 3002, Micrococcus luteus GPE 3001, and Bacillus cereus GPE 3003, with minimum inhibitory concentration (MIC) values ranging from 27 to 109 µg/mL. This study establishes a robust and cost-effective method for producing bioactive bacteriocins from inclusion bodies, underscoring their potential as sustainable alternatives to conventional antibiotics and chemical preservatives.
期刊介绍:
Molecular Nutrition & Food Research is a primary research journal devoted to health, safety and all aspects of molecular nutrition such as nutritional biochemistry, nutrigenomics and metabolomics aiming to link the information arising from related disciplines:
Bioactivity: Nutritional and medical effects of food constituents including bioavailability and kinetics.
Immunology: Understanding the interactions of food and the immune system.
Microbiology: Food spoilage, food pathogens, chemical and physical approaches of fermented foods and novel microbial processes.
Chemistry: Isolation and analysis of bioactive food ingredients while considering environmental aspects.